Decera Clinical Education Infectious Disease Podcast

Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss treatment strategies for people who are immunocompromised with COVID-19 in the hospital setting, including:  Antiviral therapy with remdesivir Dexamethasone for patients with hematologic malignancies Considerations regarding other immunomodulators such as JAK inhibitors or IL-6 inhibitors A det...

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss treatment strategies for people who have severe COVID-19, including:  Antiviral therapy with remdesivir  Dexamethasone and other systemic corticosteroids  Immunomodulators, such as JAK inhibitors or IL-6 inhibitors  Overviews of clinical trial data demonstrating how and when to use these...

In this episode, Patricia D. Jones, MD, MSCR; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and patient advocate, Jennifer Wild, MS, RN, OCN, discuss practical strategies to overcome barriers to hepatitis B virus (HBV) care, including:  Overcoming health insurance navigation  Improving access to HBV care in immigrant communities Dispelling HBV myths and stigma Solutions to language barriers Community-b...

In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss:  Workup of COVID-19 in the emergency department Methods of COVID-19 risk stratification  Treatment recommendations for people with severe COVID-19, including how to effectively use antiviral therapy, dexamethasone, and other immunomodulators [CC1] in this population  A detailed patient...

In this episode, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss the management of mild to moderate COVID-19 in patients who are immunocompromised, including: Initial workup, which may include laboratory tests and/or imaging Latest data on the use of remdesivir or nirmatrelvir plus ritonavir for mild to moderate COVID-19, including considerations for drug–drug interactions  ...

In this episode, Patricia D. Jones, MD, MSCR; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and patient advocate, Jennifer Wild, MS, RN, OCN, discuss best practices in hepatitis B virus (HBV) care, including:  2023 CDC HBV screening recommendations Summary of guideline recommendations for hepatitis delta virus (HDV) screening  Use of HDV reflex testing to avoid loss to follow-up 2024 WHO HBV treatment...

In this episode, Cristina Mussini, MD, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss: Current SARS-CoV-2 trends in the EU Risk factors for severe COVID-19 outcomes, including the spectrum of risk based on immune system status Factors that may affect vaccine efficacy in chronic lymphocytic leukemia and other lymphoid malignancies Considerations for determining people at high...

In this episode, Tzu-Hao (Howard) Lee, MD; Tatyana Kushner, MD, MSCE; and patient advocate Andrew Reynolds discuss hepatitis C virus (HCV) care in men who have sex with men and pregnant people, including: HCV disease burden in the United States Screening recommendations  Strategies to overcome barriers to HCV screening Treatment recommendations, including simplified treatment guidance and consider...

In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including: ELATIVE, a phase III trial of elafibranor for PBC RESPONSE, a phase III trial of seladelpar for PBC ASSURE, another phase III trial of seladelpar for PBC Presenter: Sonal Kumar, MD, MPH Director, Clinical Gastroenterology and Hepatology Assistant Professo...

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss current trends in and risk factors for progression to severe COVID-19, including for those for whom COVID-19 is not their primary concern when presenting to the emergency department (ED). Key topics of discussion include:  How to complete a comprehensive patient workup in the ED Consideratio...

In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics: Screening recommendations Strategies to improve HCV screening HCV testing Treatment goals Strategies to improve HCV treatment uptake Presenters: Stacey B. Trooskin, MD,...

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss best practices in treating patients hospitalized with mild to moderate COVID-19, including:  Current guidelines from the Infectious Diseases Society of America and National Institutes of Health  How to optimize therapy selection based on patient risk factors, including key data supporting be...

Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients’ quality of life. Listen as they discuss: Gaps...

Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including: Pruritus assessment tools Optimal use of tools, includ...

In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective. Presenters: Marlyn J. Mayo, MD Professor of Internal Medicine Division of Digestive & Liver Diseases UT Southwes...

In this episode, Jean-Michel Molina, MD, PhD, and Joseph J. Eron, Jr., MD, discuss results from key clinical trials on HIV prevention and treatment as well as sexually transmitted infection (STI) prevention presented at IDWeek and Glasgow 2024, including: PURPOSE 1 and 2 comparing lenacapavir injection vs oral TDF/FTC TRIO Health Cohort and OPERA examining long-acting cabotegravir as PrEP DOLCE co...

In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including: Treatment goals Use of PPAR agonists for the treatment of PBC Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO) Presenter: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and...

In this episode, a transfemme nonbinary individual living with HIV shares her experience navigating the healthcare system, alongside her infectious disease physician, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS. Hear them discuss key considerations when caring for gender-diverse individuals, including:  Understanding how people are more than just a diagnosis  Prioritizing individuals’ needs...

In this rapid webinar, Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, provide an overview of important topics and studies presented at HIVR4P 2024, including: Expanding PrEP options based on results from PURPOSE 2, IMPOWER-22, IMPOWER-24, IPM 054, MTN-025/HOPE OLE, CATALYST, and the HPTN 084 substudy Implementing injectable PrEP based on results from PEPFAR, the US...

Listen in as Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, discuss strategies to achieve health equity in HPV vaccination, including: Trends among males vs females Messaging considerations for those from diverse populations (eg, LGTBQ+ and rural communities) How healthcare professionals can address barriers to care Then, hear answers from the experts to frequently asked questions regar...

In this rapid webinar, Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, provide an overview of important topics and studies presented at HIVR4P 2024, including: Expanding PrEP options based on results from PURPOSE 2, IMPOWER-22, IMPOWER-24, IPM 054, MTN-025/HOPE OLE, CATALYST, and the HPTN 084 substudy Implementing injectable PrEP based on results from PEPFAR, the US...

Listen in as Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, discuss strategies to improve your messaging techniques with the HPV vaccine, including: Persisting in vaccine recommendation after initial refusal Educating patients and their families together Ensuring staff are trained to correctly answer questions Knowing when interested patients in your state can consent to vaccination wit...

Listen in as Sharon G. Humiston, MD, MPH, discusses current trends in HPV, including: Incidence and prevalence trends in the US Sex-related features of HPV-attributable cancers How HPV vaccination uptake can prevent certain types of cancer Current guidelines and recommendations for HPV vaccination Presenter : Sharon G. Humiston, MD, MPH Director for Research Associate Editor of IZ-Express Immunize...

In this episode, Kathleen Page, MD, and Glenn J. Treisman, MD, PhD, discuss the interplay between addiction and HIV. Learn as they share their approaches to reframing the conversation about addiction and overcoming barriers to effective addiction care for people living with HIV. Presenters: Kathleen Page, MD Professor Infectious Diseases Johns Hopkins School of Medicine Baltimore, Maryland   Glenn...

In this episode, Alexander Wong, MD, FRCPC, discusses how to optimize treatment and engagement in care for individuals with HIV and substance use disorder, including:  Barriers to care for persons with substance use disorder  Colocating HIV and other services (eg, addiction care medicine, social services)  Leveraging a multidisciplinary approach to care  Integrating a low-barrier model to foster a...